Filing Impact
Filing Sentiment
Form Type
SCHEDULE 13G
China Sxt Pharmaceuticals Inc
Mar 17, 2025
China SXT Pharmaceuticals Has Regained Compliance with Nasdaq’s Minimum Bid Price Deficiency
Oct 7, 2024
China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency
174.04M
116.02M
0.01%
0.01%
0.04%
Drug Manufacturers - Specialty & Generic
Healthcare
China
Taizhou